Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities.
View all
Exelixis
Post IPO Debt • Alameda, United States
Exact Sciences
Post IPO Debt • Madison, United States
PacBio
Post IPO Debt • Menlo Park, United States
Amicus Therapeutics
Post IPO Debt • Cranbury Township, United States
Travere Therapeutics
Post IPO Debt • San Diego, United States
Arcutis Biotherapeutics
Post IPO Debt • Westlake Village, United States
Sema4
Post IPO Equity • Stamford, United States
Aimmune Therapeutics
Post IPO Equity • Brisbane, United States
Sage Therapeutics
Post IPO Equity • Cambridge, United States
KindredBio
Post IPO Debt • Burlingame, United States
Atara Biotherapeutics
Post IPO Equity • South San Francisco, United States
QTS
Post IPO Debt • Overland Park, United States